Delivery Order SPE2DB24D2011-SPE2DB25FBRHS
Award Date 7/18/25
Potential Completion Date 8/8/25
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, a pharmaceutical product used in hormone therapy for prostate cancer treatment. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,385.52 and is scheduled for completion by August 25, 2025. The contract was issued on August 4, 2025, with no set-aside designation, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg on August 19, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, reflecting the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,385.52 firm fixed price delivery order for 30 tablets of Orgovyx 120 mg on August 4, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be performed at...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, a pharmaceutical product used in prostate cancer treatment, with a contract ceiling value of $1,385.52. The award was competitively procured without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of June 3, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 28, 2025, with completion scheduled for September 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a specialized pharmaceutical used in the treatment of prostate...
- The Defense Logistics Agency awarded a $8,313.12 delivery order to AmerisourceBergen Drug Corp for 30-count units of Orgovyx 120 mg tablets, a pharmaceutical product for prostate cancer treatment. Issued on August 19, 2025, with an ultimate completion date of September 10, 2025, this firm fixed-price contract represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $8,313.12 for 30 tablets of Orgovyx 120 mg on September 12, 2025, with an ultimate completion date of October 3, 2025. This non-competitive award was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The delivery order will be...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (quantity: 30 units) on September 5, 2025, with completion targeted for September 26, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg on September 9, 2025, with a completion date of September 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, valued at $8,313.12, with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, demonstrating the agency's ongoing need...